Wedbush initiates coverage on Monte Rosa Therapeutics. With differentiated lead programs and AI-driven QuEEN platform, the company shows strong potential for value creation.
BofA Securities upgrades Air Products & Chemicals to Buy with a price target of $264. Analyst cites valuation disconnect, lower risk in projects, and strong base business.